LISATA THERAPEUTICS, INC. Proceeds from (Repurchase of) Redeemable Preferred Stock
LISATA THERAPEUTICS, INC. (LSTA) reported Proceeds from (Repurchase of) Redeemable Preferred Stock of $2.50 million for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock · last filed 2014-03-13
- LISATA THERAPEUTICS, INC. proceeds from (repurchase of) redeemable preferred stock for fiscal 2012 was $2.50M, a 0.00% change from fiscal 2011.
- LISATA THERAPEUTICS, INC. proceeds from (repurchase of) redeemable preferred stock for fiscal 2011 was $2.50M.
| Period end | Proceeds from (Repurchase of) Redeemable Preferred Stock 12 month |
|---|---|
| 2012-12-31 | $2.50M 10-K · filed 2014-03-13 |
| 2011-12-31 | $2.50M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |